We are live on ! Find out more
ILI

INTERLEUKIN GENETICS INC
ILI

Delisted

ILI was delisted on the 13th of August, 2010.

Back to rankings

1 hedge funds and large institutions have $36K invested in INTERLEUKIN GENETICS INC in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

48% less capital invested

Capital invested by funds: $69K → $36K (-$33K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ILI Hedge Fund Activity: Q2 2017 in Review

1 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in INTERLEUKIN GENETICS INC (ILI) for Q2 2017, worth a combined $36K — down 48% from $69K a quarter earlier.

Fund positioning in ILI was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held INTERLEUKIN GENETICS INC (ILI) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $36K of INTERLEUKIN GENETICS INC stock for Q2 2017, down 48% quarter-over-quarter.
  • 0 funds opened new INTERLEUKIN GENETICS INC positions in Q2 2017 and 0 closed out.

Based on aggregated 13F filings for Q2 2017.